Innovative medication to improve the well-being of men and women.
Besins Healthcare entered the Men’s Health area in Europe in 1982 when it developed the first dihydrotestosterone gel for the treatment of hypogonadism and gynaecomastia (breast enlargement).
We built on that success and our hormone therapy expertise to develop the world’s first transdermal testosterone gel therapy to treat hypogonadism. This has made us the #1 global leader in testosterone replacement therapy.
Over the last 40 years, Besins Healthcare has discovered, developed and delivered healthcare solutions to help women successfully manage the often unexpected issues related to pregnancy, infertility and menopause. Our estrogen-based and progesterone-based products are confidently prescribed by physicians in more than 100 countries worldwide.